Outcomes and Recommendations of an Indian Expert Panel for Improved Practice in Controlled Ovarian Stimulation for Assisted Reproductive Technology
Purpose. To improve success of in vitro fertilization (IVF), assisted reproductive technology (ART) experts addressed four questions. What is optimum oocytes number leading to highest live birth rate (LBR)? Are cohort size and embryo quality correlated? Does gonadotropin type affect oocyte yield? Sh...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | International Journal of Reproductive Medicine |
Online Access: | http://dx.doi.org/10.1155/2017/9451235 |
id |
doaj-48902677913e44958d896bed9c4a7468 |
---|---|
record_format |
Article |
spelling |
doaj-48902677913e44958d896bed9c4a74682020-11-25T01:22:57ZengHindawi LimitedInternational Journal of Reproductive Medicine2356-71042314-57572017-01-01201710.1155/2017/94512359451235Outcomes and Recommendations of an Indian Expert Panel for Improved Practice in Controlled Ovarian Stimulation for Assisted Reproductive TechnologyBaiju Ahemmed0Vani Sundarapandian1Rohit Gutgutia2Sathya Balasubramanyam3Richa Jagtap4Reeta Biliangady5Priti Gupta6Sachin Jadhav7Ruma Satwik8Pavitra Raj Dewda9Priti Thakor10Sandro C. Esteves11NCARE Group of IVF Centres, Kerala, IndiaJananam Fertility Center, Chennai, IndiaNova IVI Fertility, Kolkata, IndiaCloud 9 Hospitals, Chennai, IndiaNova IVI Fertility, Mumbai, IndiaCloud 9 Fertility, Bengaluru, IndiaFertility and IVF-Jaipur Golden Hospital & Gupta Maternity Home, Delhi, IndiaGupte Hospital, Pune, IndiaCentre of IVF and Human Reproduction, Sir Ganga Ram Hospital, New Delhi, IndiaMedical Affairs, Merck Biopharma, Mumbai, IndiaMedical Affairs, Merck Biopharma, Mumbai, IndiaANDROFERT, Andrology and Human Reproduction Clinic, Referral Center for Male Reproduction, Campinas, SP, BrazilPurpose. To improve success of in vitro fertilization (IVF), assisted reproductive technology (ART) experts addressed four questions. What is optimum oocytes number leading to highest live birth rate (LBR)? Are cohort size and embryo quality correlated? Does gonadotropin type affect oocyte yield? Should “freeze-all” policy be adopted in cycles with progesterone >1.5 ng/mL on day of human chorionic gonadotropin (hCG) administration? Methods. Electronic database search included ten studies on which panel gave opinions for improving current practice in controlled ovarian stimulation for ART. Results. Strong association existed between retrieved oocytes number (RON) and LBRs. RON impacted likelihood of ovarian hyperstimulation syndrome (OHSS). Embryo euploidy decreased with age, not with cohort size. Progesterone > 1.5 ng/dL did not impair cycle outcomes in patients with high cohorts and showed disparate results on day of hCG administration. Conclusions. Ovarian stimulation should be designed to retrieve 10–15 oocytes/treatment. Accurate dosage, gonadotropin type, should be selected as per prediction markers of ovarian response. Gonadotropin-releasing hormone (GnRH) antagonist based protocols are advised to avoid OHSS. Cumulative pregnancy rate was most relevant pregnancy endpoint in ART. Cycles with serum progesterone ≥1.5 ng/dL on day of hCG administration should not adopt “freeze-all” policy. Further research is needed due to lack of data availability on progesterone threshold or index.http://dx.doi.org/10.1155/2017/9451235 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Baiju Ahemmed Vani Sundarapandian Rohit Gutgutia Sathya Balasubramanyam Richa Jagtap Reeta Biliangady Priti Gupta Sachin Jadhav Ruma Satwik Pavitra Raj Dewda Priti Thakor Sandro C. Esteves |
spellingShingle |
Baiju Ahemmed Vani Sundarapandian Rohit Gutgutia Sathya Balasubramanyam Richa Jagtap Reeta Biliangady Priti Gupta Sachin Jadhav Ruma Satwik Pavitra Raj Dewda Priti Thakor Sandro C. Esteves Outcomes and Recommendations of an Indian Expert Panel for Improved Practice in Controlled Ovarian Stimulation for Assisted Reproductive Technology International Journal of Reproductive Medicine |
author_facet |
Baiju Ahemmed Vani Sundarapandian Rohit Gutgutia Sathya Balasubramanyam Richa Jagtap Reeta Biliangady Priti Gupta Sachin Jadhav Ruma Satwik Pavitra Raj Dewda Priti Thakor Sandro C. Esteves |
author_sort |
Baiju Ahemmed |
title |
Outcomes and Recommendations of an Indian Expert Panel for Improved Practice in Controlled Ovarian Stimulation for Assisted Reproductive Technology |
title_short |
Outcomes and Recommendations of an Indian Expert Panel for Improved Practice in Controlled Ovarian Stimulation for Assisted Reproductive Technology |
title_full |
Outcomes and Recommendations of an Indian Expert Panel for Improved Practice in Controlled Ovarian Stimulation for Assisted Reproductive Technology |
title_fullStr |
Outcomes and Recommendations of an Indian Expert Panel for Improved Practice in Controlled Ovarian Stimulation for Assisted Reproductive Technology |
title_full_unstemmed |
Outcomes and Recommendations of an Indian Expert Panel for Improved Practice in Controlled Ovarian Stimulation for Assisted Reproductive Technology |
title_sort |
outcomes and recommendations of an indian expert panel for improved practice in controlled ovarian stimulation for assisted reproductive technology |
publisher |
Hindawi Limited |
series |
International Journal of Reproductive Medicine |
issn |
2356-7104 2314-5757 |
publishDate |
2017-01-01 |
description |
Purpose. To improve success of in vitro fertilization (IVF), assisted reproductive technology (ART) experts addressed four questions. What is optimum oocytes number leading to highest live birth rate (LBR)? Are cohort size and embryo quality correlated? Does gonadotropin type affect oocyte yield? Should “freeze-all” policy be adopted in cycles with progesterone >1.5 ng/mL on day of human chorionic gonadotropin (hCG) administration? Methods. Electronic database search included ten studies on which panel gave opinions for improving current practice in controlled ovarian stimulation for ART. Results. Strong association existed between retrieved oocytes number (RON) and LBRs. RON impacted likelihood of ovarian hyperstimulation syndrome (OHSS). Embryo euploidy decreased with age, not with cohort size. Progesterone > 1.5 ng/dL did not impair cycle outcomes in patients with high cohorts and showed disparate results on day of hCG administration. Conclusions. Ovarian stimulation should be designed to retrieve 10–15 oocytes/treatment. Accurate dosage, gonadotropin type, should be selected as per prediction markers of ovarian response. Gonadotropin-releasing hormone (GnRH) antagonist based protocols are advised to avoid OHSS. Cumulative pregnancy rate was most relevant pregnancy endpoint in ART. Cycles with serum progesterone ≥1.5 ng/dL on day of hCG administration should not adopt “freeze-all” policy. Further research is needed due to lack of data availability on progesterone threshold or index. |
url |
http://dx.doi.org/10.1155/2017/9451235 |
work_keys_str_mv |
AT baijuahemmed outcomesandrecommendationsofanindianexpertpanelforimprovedpracticeincontrolledovarianstimulationforassistedreproductivetechnology AT vanisundarapandian outcomesandrecommendationsofanindianexpertpanelforimprovedpracticeincontrolledovarianstimulationforassistedreproductivetechnology AT rohitgutgutia outcomesandrecommendationsofanindianexpertpanelforimprovedpracticeincontrolledovarianstimulationforassistedreproductivetechnology AT sathyabalasubramanyam outcomesandrecommendationsofanindianexpertpanelforimprovedpracticeincontrolledovarianstimulationforassistedreproductivetechnology AT richajagtap outcomesandrecommendationsofanindianexpertpanelforimprovedpracticeincontrolledovarianstimulationforassistedreproductivetechnology AT reetabiliangady outcomesandrecommendationsofanindianexpertpanelforimprovedpracticeincontrolledovarianstimulationforassistedreproductivetechnology AT pritigupta outcomesandrecommendationsofanindianexpertpanelforimprovedpracticeincontrolledovarianstimulationforassistedreproductivetechnology AT sachinjadhav outcomesandrecommendationsofanindianexpertpanelforimprovedpracticeincontrolledovarianstimulationforassistedreproductivetechnology AT rumasatwik outcomesandrecommendationsofanindianexpertpanelforimprovedpracticeincontrolledovarianstimulationforassistedreproductivetechnology AT pavitrarajdewda outcomesandrecommendationsofanindianexpertpanelforimprovedpracticeincontrolledovarianstimulationforassistedreproductivetechnology AT pritithakor outcomesandrecommendationsofanindianexpertpanelforimprovedpracticeincontrolledovarianstimulationforassistedreproductivetechnology AT sandrocesteves outcomesandrecommendationsofanindianexpertpanelforimprovedpracticeincontrolledovarianstimulationforassistedreproductivetechnology |
_version_ |
1725124388584423424 |